Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.315
-0.030 (-0.90%)
Nov 6, 2025, 1:23 PM EST - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $1.19 billion as of November 6, 2025. Its market cap has decreased by -6.10% in one year.
Market Cap
1.19B
Enterprise Value
1.47B
1-Year Change
-6.10%
Ranking
Category
Stock Price
$3.32
Market Cap Chart
Since the IPO on November 2, 2010, Evotec SE's market cap has increased from $366.30M to $1.19B, an increase of 223.78%. That is a compound annual growth rate of 8.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 1.19B | -21.33% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | 38.57% |
| Dec 30, 2020 | 6.08B | 56.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 797.79B |
| Johnson & Johnson | 449.86B |
| AbbVie | 374.16B |
| UnitedHealth Group | 296.57B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.55B |